We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Philip Morris International Inc | NYSE:PM | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 94.94 | 57 | 09:00:08 |
From May 2019 to May 2024
By Colin Kellaher
Philip Morris International Inc. on Monday said it named Jorge Insuasty chief life-sciences officer, effective Jan. 15.
The tobacco company said Mr. Insuasty joins from Sanofi S.A., where most recently he was global franchise head of immunology, oncology and neurology for Sanofi Genzyme.
Philip Morris said Mr. Insuasty succeeds John O'Mullane, who is retiring.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
January 11, 2021 09:50 ET (14:50 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Philip Morris Chart |
1 Month Philip Morris Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
